Resumo

ROJAS RONDON, Irene et al. Use of intravitreal triamcinolone in patients with iris rubeosis. Rev Cubana Oftalmol [online]. 2008, vol.21, n.2, pp. 0-0. ISSN 1561-3070.

OBJECTIVE: To describe the behaviour of iris rubeosis after using intravitreal triamcinolone. METHODS: A longitudinal descriptive study was performed on 25 patients for a total number of 32 eyes with several ocular diseases. Statistical tests were made with the study variables; sign comparison for paired data and Chi square tests were applied. The variables were age, sex, cause of iris rubeosis and its staging, symptoms and treatment with retinal photocoagulation laser. RESULTS: Proliferative diabetic retinopathy was the most common disease in 76% of patients, followed by central retinal vein occlusion. Of the total number of treated patients, 37,5 % had satisfactory recovery in terms of the iris rubeosis condition. The number of patients that improved rubeosis condition after a combined therapy of laser and intravitreal triamcinolone was higher but not statistically significant. Rubeosis condition improved in over 50 % of patients whose rubeosis had developed in less than six months. However, in those patients with the disease affecting them for more than 6 months and third grade iris neovascularization, neovascular glaucoma could be stabilized. CONCLUSION: Intravitreal triamcinolone is an alternative for the management of this type of patients.

Palavras-chave : Iris rubeosis; intraocular pressure; diabetic retinopathy; neovascular glaucoma; intravitreal triamcinolone.